Axitinib—a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor
✍ Scribed by Ronan J. Kelly; Olivier Rixe
- Book ID
- 107384366
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 215 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1776-2596
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
## Abstract Angiogenesis, the formation of new blood vessels, is controlled by a balance between positive and negative endothelial regulatory factors. Soluble vascular endothelial growth factor receptor‐1 (sVEGFR1), a naturally occurring soluble form of VEGFR1, is a negative counterpart of the vasc